A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 136.66
GOOG 828.64
MSFT 64.62
FB 135.44
BAC 24.23

Recently Added

STRL 9.32
LAYN 9.54
NOA 5.35
LL 17.39
WGL 83.28

Gaining Speed

BLBD 16.70
ATGFF 23.60
WGL 83.28
LAYN 9.54
STRL 9.32

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!